News Hub | News Direct

Consumer

Baby/Maternity Children Family LGBT Men Religion Teens Women
Article thumbnail News Release

HUSQVARNA® VIKING® Introduces Epic Quilt™ 97

SVP Worldwide

SVP Worldwide, the parent company of HUSQVARNA® VIKING®, a leader in the sewing industry, proudly announced today the launch of its latest innovation, the Epic Quilt™ 97, what quilt dreams are made of. The Epic Quilt™ 97 boasts a spacious workspace perfect for large projects, accommodating even king-sized quilts. With over 12" (310mm) to the right of the needle and a working area height exceeding 5.5" (140mm), it provides ample room for handling bulky materials. A particular standout feature of the Epic Quilt™ 97 is its sewing projection technology, allowing quilters to preview their stitches before sewing. Stitch preview ensures perfect placement every time. The adjustable lines, angles, and grids in sewing mode make aligning stitches effortless, saving valuable time while achieving precision. The Epic Quilt™ 97 also comes equipped with meticulously designed accessories that enhance creativity and ease of use. Included are advanced accessories providing quilters with the tools needed to elevate their craft to new heights including an Extension Table with Adjustable Guide, Rotating Self Healing Cutting Mat (12” x 12”), Rotary Cutting Tool + Replacement Blades, Ruler Set (6” x 12” and 6” x 6” sizes), Free Motion Ruler Foot, Quilt Binder, HUSQVARNA® VIKING® Universal Needles 80/12 5-Pack and the HUSQVARNA® VIKING® Quilting Needles Assorted Sizes 5-Pack. "We are excited to unveil the Epic 97Q, a groundbreaking advancement in our tradition of innovation,” stated Jason Zielke, chief product officer at SVP Worldwide. “Leveraging AI technology, the machine recommends the optimal sewing foot setup for each stitch, and the built-in projection system simplifies the process of creating complex stitches leading to exceptional precision and quality. We added to this machine a suite of the most important accessories that will advance the quilting experience. The Epic 97Q combines our rich heritage with cutting-edge technology, empowering you to create intricate, beautifully executed quilts with unparalleled ease and accuracy." The Epic Quilt 97 is now available online. For more information, please visit our website at www.husqvarnaviking.com. Media Assets About SVP Worldwide SVP Worldwide is the world’s largest consumer sewing machine company, accounting for approximately one out of every three sewing machines sold globally. The company’s iconic brands - SINGER®, VIKING®, PFAFF®, and mySewnet™, have collectively delighted consumers for over 170 years with a distinct heritage and global fanbase. These premium brands and products are regarded as the first-rate choice for a range of consumers from serious sewists to beginners in crafting. SVP Worldwide operates facilities around the globe that support designing, manufacturing, selling, and supplying the world’s most iconic sewing machine brands. Headquartered out of Nashville, TN (USA) with operations internationally, SVP Worldwide boasts regional headquarters, manufacturing facilities, and commercial offices across Europe, South America, Asia, and Australia. Combined, SVP reaches consumers in more than 180 countries on five continents. SVP brands and products are sold online at www.Singer.com and across a network of sewing machine dealers, mass, online, and specialty retailers, distributors, and through the company’s 130+ internally operated retail stores. In 2021, Platinum Equity acquired the controlling stake in SVP-Singer Holdings, Inc., and its wholly owned subsidiaries ("SVP Worldwide"). To learn more, visit www.svpworldwide.com. Contact Details Razor Sharp PR Ray Young +1 512-694-6097 ray@razorsharppr.com

October 10, 2024 10:00 AM Central Daylight Time

Article thumbnail News Release

Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit

Silexion Therapeutics Corp

Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced its participation in the 2024 Maxim Healthcare Virtual Summit, scheduled to take place from October 15 to 17, 2024. Ilan Hadar, Chief Executive Officer and Dr. Mitchell Shirvan, Chief Scientific and Development Officer will join a fireside chat hosted by Jason McCarthy, Senior Managing Director and Head of Biotechnology Research at Maxim Group, on Thursday, October 17, 2024, at 9:30am ET. The event will be streamed live on M-Vest and accessible to members by clicking here or via following link: https://m-vest.com/events/healthcare-10152024. The Company’s management team will be available for one-on-one meetings throughout the summit. Interested investors are encouraged to contact their Maxim representative to schedule a meeting. About Silexion Therapeutics: Silexion Therapeutics (NASDAQ: SLXN) is a pioneering clinical-stage, oncology-focused biotechnology company developing innovative RNA interference (RNAi) therapies to treat solid tumors driven by KRAS mutations, the most common oncogenic driver in human cancers. The company's first-generation product, LODER™, has shown promising results in a Phase 2 trial for non-resectable pancreatic cancer. Silexion is also advancing its next-generation siRNA candidate, SIL-204, designed to target a broader range of KRAS mutations and showing significant potential in preclinical studies. The company remains committed to pushing the boundaries of therapeutic innovation in oncology, with a focus on improving outcomes for patients with difficult-to-treat cancers. For more information please visit: https://silexion.com Contact Details Silexion Therapeutics Corp Ms. Mirit Horenshtein Hadar, CFO mirit@silexion.com ARX | Capital Markets Advisors North American Equities Desk silexion@arxadvisory.com

October 09, 2024 04:30 PM Eastern Daylight Time

Article thumbnail News Release

Equality CA Presents 2024 Community Leadership Award to Greg Sarris

Federated Indians of Graton Rancheria

Equality CA, the nation’s largest statewide LGBTQ+ civil rights organization, presented Tribal Chairman Greg Sarris with their annual Community Leadership Award at their gala in Los Angeles. The award celebrates Chairman Sarris’ longtime service to equal rights, and was presented by California State Treasurer, Fiona Ma. In presenting the award, Ma commented, “I'm thrilled to present honoree Dr. Greg Sarris, whose activism and philanthropic efforts over many years have improved the lives of so many. He has also been incredibly generous in supporting LGBTQ causes and uplifting underrepresented communities.” Chairman Sarris commented, “In Los Angeles this past Saturday, I was presented with the Community Leadership Award from Equality, California. I accepted this award on behalf of and in recognition of my wonderful Tribe, the Federated Indians of Graton Rancheria. Our Tribal Council has generously supported not just Equality California but a host of other organizations and causes in line with our mission of social justice and environmental leadership. This particular honor was special to me. I believe service to others and the larger world is needed now more than ever, and certainly is in line with the beliefs and life ways of our Southern Pomo and Coast Miwok ancestors. Whether university teaching for over 35 years, Tribal leadership for over 30 years and writing several books with the hope of educating others, I’ve lived my best moments in service. Thank you, Tribal Council and all Tribal Citizens of Federated Indians of Graton Rancheria, thank you students and book publishers for enabling me to live my best life.” About the Federated Indians of Graton Rancheria Graton Rancheria is a federally recognized Indian tribe comprised of Coast Miwok and Southern Pomo Indians. Legislation restoring federal recognition to the Federated Indians of Graton Rancheria was signed into law in December 2000. Tribal lands are located in Rohnert Park, Sonoma County, CA. For more information about FIGR, visit www.gratonrancheria.com. Contact Details Landis Communications Inc. Brianne Miller +1 415-766-0887 graton@landispr.com Company Website https://gratonrancheria.com/

October 08, 2024 01:41 PM Pacific Daylight Time

Image
Article thumbnail News Release

Activate Games is Coming to Detroit: Immersive Gaming Experience Set to Energize Utica with FREE Grand Opening Weekend

Activate

Activate, the pioneering force behind the world’s first active gaming experience, is thrilled to announce the opening of its newest location right in the heart of Utica, Michigan. The grand opening will take place on Oct. 11, 2024. Guests are invited to dive into the world of immersive gameplay and experience game rooms filled with eye-catching colored lights, LED screens and lasers that make you feel like you stepped through the screen of your favorite video game. The extraordinary venue will bring a new light of excitement to the city of Utica at its new location at 45330 Utica Park Boulevard, Utica, MI 48315. From Oct. 11 to Oct. 13, Activate is celebrating the grand opening of the Detroit location with free admission all weekend long. Locals and visitors can secure their spots here to experience Activate’s one-of-a-kind immersive gaming and compete in a variety of interactive challenges that combine physical activity and skill testing challenges. Whether you're a seasoned gamer or a first-time player, the Detroit community is invited to explore the facility, dive into thrilling adventures, and discover why Activate is quickly becoming a must-visit entertainment destination across North America. “We're excited to bring our innovative immersive gaming experience to the Detroit Metro area," said Will Gray, Director of Marketing at Activate. "Our goal has always been to create a space where people of all ages can come together, get active, and challenge themselves in ways they never have before. The energy and spirit of Detroit make it the perfect location for our newest venue, and we can’t wait to welcome the community to be part of the action during our grand opening weekend.” Following successful launches in Chicago, Kansas City, and Columbus, Activate Detroit invites players of all ages and skill levels to explore and create their unique gaming experiences. Here’s what to expect: 14 different game rooms to conquer; with the full gaming experience lasting 75 minutes. Gaming rooms include the TikTok viral sensation Mega Grid with 500+ multi-activated tiles, blasting the beaming bullseye in a game called Strike, and feeling like a modern-day spy in the Laser room. Guests can sign up in groups of two to five players. Through progress tracking via Activate’s high-tech electronic RFID wristbands, players can rack up points, leveling up and earning prizes along the way. Try Level 1 easy or take it to Level 10 extreme. Play as a team in cooperative mode, or challenge your friends in competitive mode games. As the first active gaming facility to become a TikTok sensation, Activate has built a social media empire, captivating millions with its innovative, interactive experiences.Now with 40 locations across the United States and Canada and expanding internationally to the UK, Ireland, and Dubai, Activate is taking over the immersive gaming world and it shows no signs of slowing down. PLAN YOUR VISIT Wear activewear and flat, closed-toe shoes. Where: 45330 Utica Park Boulevard Utica, MI 48315. When: Monday through Thursday, 10 a.m to 10 p.m. | Friday, 10 a.m to 11 p.m | Saturday, 9 a.m. to 11 p.m. | Sunday, 9 a.m. to 10 p.m. Cost: Starting at $19.99 per player Mon-Thurs and $24.99 per player Fri-Sun (and Holidays). For a sneak peek into Activate’s dynamic gaming experience, click here. Join the Inner Circle to be the first to hear about new locations, behind-the-scenes information, deals, and more. Please find imagery assets here. Activate is the world’s first active gaming experience where players #EnterTheGame. Activate offers a unique blend of physical activity and gaming that promotes a healthy lifestyle. Each Activate location provides fun and interactive rooms for players to compete, earn stars and track achievements. With the global headquarters located in Winnipeg, Canada, Activate has grown to 30 locations across Canada, the U.S. and now the world! To join the active gaming movement, visit playactivate.com. Follow Activate on social media: Facebook: Activate Instagram: @activategames TikTok: @activategames Contact Details Jalila Singerff +1 613-614-6777 jalila@jiveprdigital.com Company Website https://playactivate.com

October 08, 2024 08:00 AM Eastern Daylight Time

Article thumbnail News Release

Focal Chooses SPARK Microsystems’ UWB Wireless Tech for New HiFi DIVA UTOPIA Speakers

SPARK Microsystems

SPARK Microsystems, a Canadian fabless semiconductor company specializing in next-generation short-range wireless communications, today announced its collaboration with Focal, the renowned French audio brand, in the development of the revolutionary DIVA UTOPIA loudspeaker. This collaboration brings together Focal’s expertise in high-fidelity audio with SPARK’s Ultra-Wideband (UWB) technology, delivering a high-performance wireless audio experience. The DIVA UTOPIA is Focal’s first connected, wireless active loudspeaker, designed to meet the demands of those seeking exceptional sound quality with the convenience of modern wireless technology. SPARK’s SR1020 wireless transceiver leverages UWB technology to supply the data transmission between the two speakers, delivering uncompressed audio with ultra-low latency, setting a new standard for wireless audio performance. “Our collaboration with Focal showcases the advantages of SPARK’s UWB in delivering high-resolution audio without the limitations of traditional wireless technologies,” said Julie Delamarre, SPARK Microsystems, Senior Vice President of Worldwide Sales. “The DIVA UTOPIA is a great example of how a UWB wireless connection ensures every note is transmitted with the highest fidelity.” SPARK’s UWB connectivity allows for a seamless wireless connection between the two DIVA UTOPIA loudspeakers, maintaining a stable and lossless signal at 96kHz/24bit resolution. This advanced technology eliminates the need for wires while preserving the quality of sound typically associated with wired connections. With support for major streaming platforms and wireless protocols, the DIVA UTOPIA offers a versatile and intuitive user experience. SPARK’s UWB technology supports multiroom configurations, making it easier than ever to integrate the DIVA UTOPIA into a complete home music ecosystem. "The DIVA UTOPIA represents a new era in high-fidelity audio. By integrating SPARK Microsystems' UWB technology, we have created a loudspeaker that not only delivers exceptional sound quality but also offers the freedom and flexibility that today’s consumers demand,” said Rejean Bedel, Focal & Naim, Group Marketing Manager. “This partnership is a testament to our commitment to pushing the boundaries of innovation and redefining the listening experience." The DIVA UTOPIA loudspeakers are now available exclusively at qualified Focal Powered by Naim stores. For more information, visit Focal's website. About Focal Since 1979, Focal has stood out from the crowd in manufacturing loudspeakers and acoustic speakers. Their expertise extends to headphones, car audio kits, professional speakers, and installations for yachts. This unique know-how, combined with their in-house manufacturing in France, puts Focal among the top audio brands globally. In 2011, Focal joined forces with Naim — the British leader in high-end electronics — under the VerVent Audio group to offer exquisite complete audio systems. Visit www.focal.com for more. About SPARK Microsystems​ SPARK Microsystems is building next generation short-range wireless communication devices. SPARK provides high data rate and very low latency wireless communication links at an ultra-low power profile, making it ideal for personal area networks (PANs) used in mobile, consumer and IoT-connected products. Leveraging patented technologies, SPARK Microsystems strives to minimize and ultimately eliminate wires and batteries from a wide range of applications while delivering a wired-like performance. For more information, please visit www.sparkmicro.com.​ Contact Details Jenna Desimone +1 508-340-6851 jdesimone@rainierco.com Company Website https://www.sparkmicro.com

October 02, 2024 12:03 PM Eastern Daylight Time

Image
Article thumbnail News Release

Comcast Unveils Xfinity Rewards Hot Air Balloon in Clovis

Comcast California

Comcast is proud to announce its participation in the 49th annual ClovisFest & Hot Air Balloon Fun Fly, taking place from September 28-29, 2024, in Clovis, California. Comcast will bring its Xfinity Rewards branded hot air balloon to California for the first time at the iconic Central Valley event, offering attendees a unique and immersive experience. "Our participation in ClovisFest is a wonderful opportunity to connect with our customers and the broader community in a meaningful way,” said Justin Minniti, Area Vice President at Comcast in California. “The Xfinity Rewards hot air balloon symbolizes our commitment to providing extraordinary customer experiences. The balloon also symbolizes Comcast’s commitment to our communities through Project UP, a $1 billion investment to advance digital equity, foster economic mobility and open doors for the next generation of innovators.” “We are excited to have the Xfinity Rewards hot air balloon join our stellar lineup this year,” said Greg Newman, President and CEO of the Clovis Chamber of Commerce. “On behalf of the Clovis Chamber of Commerce and the Clovis community, we thank Comcast for its participation in and support of the festival that benefits thousands of business owners in the area and is a staple for Central Valley families and visitors.” The Xfinity Rewards hot air balloon will be prominently featured at the event, inviting attendees to sign up for Xfinity Rewards and learn more about the exclusive benefits available to its members. Eventgoers can also visit the Xfinity booth for interactive experiences and giveaways. Xfinity Rewards unlocks access to unforgettable experiences, the latest technologies, and perks and discounts that only Comcast NBCUniversal can deliver. Joining Xfinity Rewards is free for customers. Signing up is fast and easy through the Xfinity App or online at xfinity.com/rewards. Upon enrolling, members are placed in a Silver, Gold, Platinum or Diamond tier based on how long they’ve been a customer. Rewards are available immediately upon signing up for the program so members can start exploring and enjoying them right away with exciting new opportunities added frequently throughout the year. About the Xfinity Rewards Hot Air Balloon The 85 feet tall Lindstrand Balloon was created in 2022 to promote Comcast’s Xfinity Rewards Program. It features eight three-dimensional 23 feet tall hearts. More than 1,234 pieces of material were used to create the hearts. It holds three passengers at a time – the pilot plus two riders. Lindstrand is a prominent balloon manufacturer in the United States. About Comcast Corporation Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company. From the connectivity and platforms we provide, to the content and experiences we create, our businesses reach hundreds of millions of customers, viewers, and guests worldwide. We deliver world-class broadband, wireless, and video through Xfinity, Comcast Business, and Sky; produce, distribute, and stream leading entertainment, sports, and news through brands including NBC, Telemundo, Universal, Peacock, and Sky; and bring incredible theme parks and attractions to life through Universal Destinations & Experiences. Visit www.comcastcorporation.com for more information. Contact Details Adriana Arvizo +1 925-200-1919 Adriana_Arvizo@comcast.com Company Website https://california.comcast.com/

September 27, 2024 07:00 AM Pacific Daylight Time

Image
Article thumbnail News Release

Former USC Student-Athlete L Simpson Launches "Take No L’s" Collection with Shiekh at USC Village

Full Scope PR

Current USC student, former USC football player and fashion entrepreneur L Simpson is rewriting the playbook for student-athletes with the exclusive launch of his highly anticipated streetwear collection, “Take No L’s”, at Shiekh at USC Village on Sept. 26. What began as a middle school project has evolved into a brand that embodies a mindset of relentless determination: no losses, only lessons – whether it’s on the court, field or in life. “Take No L’s” gained significant traction throughout Simpson’s high school basketball career at Sierra Canyon High School (Chatsworth, Calif.), where he captained his team to back-to-back California Open State Championships alongside notable teammates Scottie Pippen Jr., KJ Martin, Cassius Stanley and Christian Koloko. The brand’s momentum continued to increase when he joined USC’s renowned football program. Coached by USC head coach Lincoln Riley alongside former teammates and current NFL players, Caleb Williams, Jordan Addison and Brenden Rice, “Take No L’s” quickly became a regularly worn brand among his teammates and coaches. “I’m thrilled for L,” said USC head coach Lincoln Riley. “It’s always great to watch our players achieve their dreams, both on and off of the field. Whether we’re on campus or around the city, our players and staff love wearing the brand. L is extremely bright and innovate, and I know he is going to be incredibly successful.” “This launch is special,” says Simpson. “I shopped at Shiekh as a kid. Whenever Jordans would drop or when I wanted new athletic gear, I would always ask my parents to take me to Shiekh. It truly does feel like a full- circle moment. We’re not just selling clothes; we’re promoting a mindset of going after your dreams and never accepting defeat. That’s what Take No L’s stands for—no losses, just lessons.” Take No L’s is a bold, confident and unapologetic premium streetwear brand featuring striking graphics and vibrant colors. The collection includes hoodies, cropped sweatshirts, t-shirts, sweatpants and hats, with prices ranging from $90 to $200. With significant attention from L’s influencer network, which boasts a combined reach of over 100 million followers, the brand is already generating buzz on social media. Join Simpson on Sept. 26 from 3 p.m. to 6 p.m. PT at Shiekh in USC Village for the official launch of the “Take No L’s” collection. Experience firsthand why “Take No L’s” is setting a new standard in streetwear. The event will include special appearances, exclusive products and live entertainment featuring stars like Storm Reid, Brenden Rice, Riri Simpson, Jazz Hill, Temi Ojoro, Tade Ojoro, Ceyair Wright, Amber Jasmine, Lboogz, and Saint Thomas. Don't miss this exciting celebration of fashion and culture! About L Simpson: L Simpson, current USC student and former student-athlete, is the founder of the “Take No L’s” brand. Inspired by sports, culture and the journey of perseverance, Simpson created “Take No L’s” to encourage people to live fearlessly and embrace a lifestyle without losses. Simpson’s collection combines bold design, high-quality fabrics and empowering messaging to create a distinctive streetwear line that resonates with today’s generation. L has previously hosted his own talk show on SLAM and recently co-hosted the “Almost Pro” podcast with former Heisman Trophy winner Caleb Williams. Simpson is currently pursuing a degree in communication from the USC Annenberg School of Communication and Journalism, and he will graduate in the spring of 2025. For more info on the brand, visit takenolsstore.com and follow Simpson on Instagram at @lboogz. About Shiekh Shoes: Style Elevated, Sneakers Celebrated. Shiekh offers a curated collection of footwear, apparel, and accessories. Explore top brands like Nike, Adidas, and Jordan at Shiekh. Shiekh stores can be found at premium locations in multiple states. For more information follow @Shiekh on Instagram and visit Shiekh.com Media Contact: Pia Malihi | Full Scope PR pia@fullscopepr.com # # # Contact Details Pia Malihi pia@fullscopepr.com Company Website https://takenolsstore.com/

September 26, 2024 01:12 AM Eastern Daylight Time

Image
Article thumbnail News Release

Little Spoon Becomes The First and Only Baby Food Maker In the U.S. To Publicly Set EU-Aligned Safety Standards and Share Test Results for Heavy Metals, Pesticides + Plasticizers

Little Spoon

In a groundbreaking move for the baby food industry, Little Spoon, the largest online baby and kids food company in the United States, today becomes the first and only brand in the country to unveil its testing standards and results for heavy metals, pesticides and plasticizers, making a commitment to never sell any product that falls short of its strict limits. The launch of this significant transparency initiative comes in response to the ongoing national discussion about baby food safety, the urgent need for stricter industry standards, and staggering statistics from a recently commissioned study of 2,000 American parents with children under 2 years old. As national conversations on baby food safety rapidly gain steam, it has become impossible to ignore the concerning headlines on toxic levels of heavy metals, grocery store brand misinformation and deteriorating consumer trust. Little Spoon partnered with Talker Research to conduct a survey of 2,000 American Parents to pulse check the needs and standards of American parents, and the results uncovered astonishing levels of mistrust and concern around industry safety, federal regulations, and overarching brand commitment. In fact, 95% of parents agree that baby food brands should be doing more to address baby food safety concerns— and only 9% report a ‘high degree’ of trust in baby food companies. “Quality nutrition and confidence in the products that fuel your family are rights, not privileges.” said co-founder and CEO, Ben Lewis. “We view this as a fundamental responsibility for our industry and a key reason why Little Spoon exists in the first place. The standards for children’s food in the U.S. are maddeningly low. Parents deserve better, and we are doing our part to finally deliver what they deserve.” Established to bring change to a century old industry, Little Spoon is once again raising the bar in the category by testing and sharing results for every batch of baby food for 500+ contaminants including heavy metals, pesticides, glyphosate and plasticizers. With no current federal regulations set for limiting the levels of chemical contaminants in baby food in the U.S., Little Spoon has aligned its testing standards for heavy metals with the European Union (EU), a long-standing, trusted standard for safety and excellence in the baby space. Consumers can see exact testing limits for each contaminant through a dashboard viewable for every Babyblend product on the brand’s website and can confidently purchase products knowing Little Spoon will not sell any products that do not meet these standards. “This generation is plagued by concern regarding baby food safety — and for good reason.” said co-founder and Chief Product Officer of Little Spoon, Angela Vranich. “We have always crafted our products with the utmost care, using certified organic ingredients and differentiated processing. We knew we could meet the rigorous EU testing limits for heavy metals in our baby food, and it quickly became our obsession to provide the level of transparency parents truly deserve.” To draw further attention to this crucial issue for Little Spoon consumers and parents nationwide, the ‘Little Spoon, Big Change’ initiative will be driven by a comprehensive 360-degree marketing campaign launching today. Designed to meet parents’ growing demands for transparency and baby food safety, the campaign will feature media partners, celebrities, tastemakers, and experts including an expanded advisory panel which now features world-class experts in public policy and academics specializing in heavy metals. As a topic often fraught with fear mongering tactics, Little Spoon is leveraging experts, educators and a new AI-powered chatbot on their site to provide education for parents and support the wide-ranging questions that come with baby food safety. "We won't see large-scale changes until companies like Little Spoon take action," said Dr. Bruce Lanphear, an advisor to Little Spoon who studies childhood exposure to toxic chemicals. "Companies don't need to wait for regulations—they can lead the charge.” Test results for every Little Spoon Babyblend, alongside detailed ingredient sourcing information are now available on LittleSpoon.com, with plans to roll out additional transparency measures for their robust portfolio of products in the coming months. For complete details on the ‘Little Spoon, Big Change’ initiative including Little Spoon’s testing process, regulation limits, test results, and overall commitment to baby food safety, please visit LittleSpoon.com and follow @littlespoon on Instagram. Little Spoon is the leading direct-to-consumer kid’s food brand on a mission to make parents' lives easier, and kids healthier through high-quality, accessible feeding solutions from baby’s first bites through the big kid years. Little Spoon is conveniently delivering the future of kid’s food right to parent’s doorsteps with integrated products that age with your child through a portfolio of freshly-made baby food, early finger foods, toddler + big kid meals, and snacks that meet the modern standard on quality, nutrition and value. Since launch, the company has delivered more than 50 million meals, helping to simplify the lives of hundreds of thousands of parents across the U.S.. With more than 90% of new parents identifying as millennials, Little Spoon is here to disrupt the +$100B children's health and wellness market, offering modern solutions, trusted resources, and new ways to connect with a network of advisors and parents just like you. Learn more at LittleSpoon.com, or find Little Spoon on Instagram at @LittleSpoon. Contact Details Powers PR Alex Turk +1 516-306-2373 alext@powers-pr.com

September 25, 2024 09:03 AM Eastern Daylight Time

Image
Article thumbnail News Release

Industry Update: 3 Exciting Precision Oncology Players to Watch Following Summit’s Meteoric Rise: Silexion, Nuvectis, Scorpian

Global Markets News

Summit Therapeutics (NASDAQ: SMMT) recently captured headlines with the release of its Phase 3 data for ivonescimab, a targeted NSCLC therapy that has generated substantial buzz. The results from its trial conducted in China showed a dramatic 49% reduction in the risk of disease progression or death compared to Merck’s Keytruda, signaling a potentially disruptive force in NSCLC treatment. However, the news wasn’t without its concerns—since the trial data originates from China, there are questions about its applicability to broader, global populations. As noted by BMO Capital Markets’ Evan Seigerman: “Results may or may not be generalizable beyond the China-focused patient population initially assessed.” Despite this, Summit’s valuation has risen by over 100%, now approximating $19 billion. With such a high valuation, the company could see limited room for further significant gains, leading many in the industry to explore other emerging opportunities in precision oncology. Alongside Summit, there are quite a few other players in the field. Some if these companies have even already shown promising initial results and could see similar success in the future if they were to report positive results. These emerging players are worth watching for those interested in following precision oncology drug candidates and pipelines. Among them are precision oncology innovators such as Silexion Therapeutics, Nuvectis Pharma, and Scorpion Therapeutics, which we discuss below. Silexion Therapeutics: Disrupting the KRAS-Driven Cancer Space Silexion Therapeutics (NASDAQ: SLXN) is another under-the-radar player in the precision oncology space, with a focus on KRAS-driven cancers—a notoriously difficult target in oncology. While current small-molecule KRAS inhibitors are making progress, they are often limited to specific mutations, such as KRAS G12C, which accounts for a small percentage of cancers. Silexion’s RNA interference (RNAi) approach offers a broader solution, targeting a wider spectrum of KRAS mutations, particularly in pancreatic cancer, one of the deadliest and most treatment-resistant cancers. At the heart of Silexion’s approach is its LODER™ platform, which delivers siRNA directly to the tumor site, silencing KRAS mutations at the genetic level. This localized delivery not only increases efficacy by concentrating the treatment in the tumor, but it also reduces systemic side effects. Silexion’s next-generation candidate, SIL-204, is an optimized siRNA formulation designed to target pan-KRAS G12x mutations, positioning it to treat a broader range of KRAS-driven cancers beyond pancreatic cancer, such as lung and colorectal cancers. In Phase 2 trials for locally advanced pancreatic cancer, Silexion's LODER™ platform showed a 9.3-month improvement in overall survival when combined with standard chemotherapy. Additionally, the objective response rate (ORR) increased from 20% with chemotherapy alone to 55% with the combination, and in some cases, tumors that were initially non-resectable became operable after treatment with LODER™. These results are especially encouraging given the limited options available for pancreatic cancer patients. SIL-204, is expected to enter Phase 2/3 clinical trials in 2025-2026. What makes Silexion particularly intriguing is its current market valuation. Valued at aproximatly just ~$9 million following its SPAC merger, the company’s valuation could be perceived as low when compared to some of its peers, especially given its innovative technology and promising clinical achievements. Some have wondered whether this low valuation has more to do with dynamics post-SPAC companies. If Silexion can report positive results in its later-stage trials, the company’s outlook could dramatically improve, reflecting the potential of its RNAi-based platform. Like NXP900, SIL-204 could potentially have vast applications across multiple KRAS-driven cancer types, making Silexion a company to watch closely as it advances through clinical development. Nuvectis Pharma: Targeting NSCLC and Beyond by Inhibiting SRC/YES1 Kinases Nuvectis Pharma (NASDAQ: NVCT) has been quietly making strides in the precision oncology sector, developing innovative therapies aimed at overcoming treatment resistance in hard-to-treat cancers. Its lead candidate, NXP900, targets NSCLC by inhibiting the SRC/YES1 kinases, which play critical roles in cancer cell survival and resistance to current therapies. This approach positions NXP900 as a potential game-changer in the treatment of NSCLC, particularly in patients who have developed resistance to EGFR and ALK inhibitors, such as AstraZeneca’s Tagrisso and Novartis’ Alecensa. NXP900 is still in the early stages of clinical development, currently undergoing Phase 1 trials. However, preclinical studies have already shown that it has strong anti-tumor activity in resistant NSCLC models. Even more promising is its potential application beyond NSCLC. Like Summit's ivonescimab, NXP900 focuses on resistance, but it also has broader applications due to its ability to target multiple cancer types driven by SRC/YES1 pathways. This versatility makes it a promising asset not just for NSCLC but also for other difficult-to-treat cancers like squamous cell carcinomas. In addition to NXP900, Nuvectis is advancing NXP800, another precision oncology candidate that is further along in the clinical development process. NXP800 is currently in Phase 1b trials, targeting ARID1a-mutated cancers such as ovarian and endometrial cancers. The early clinical data for NXP800 is promising, showing positive responses in patients with platinum-resistant ovarian cancer. With two strong candidates in the pipeline, Nuvectis is positioning itself as a formidable player in the precision oncology landscape. As Summit’s ivonescimab continues to gain attention, Nuvectis’ earlier-stage NXP900, with its NSCLC focus and beyond, could see similar success in the future if clinical results continue to trend positively. Scorpion Therapeutics: Pioneering Mutant-Selective Therapies Scorpion Therapeutics is redefining the frontier of precision oncology with its focus on delivering highly selective small molecules targeting validated and previously undruggable cancer mutations. Its lead candidate, STX-478, is a mutant-selective, allosteric PI3Kα inhibitor currently in Phase 1/2 trials for advanced solid tumors. Early data presented at the ESMO Congress 2024 highlighted its potential, with STX-478 demonstrating a 23% overall response rate in breast cancer and a 21% response rate across all tumor types, positioning it as a potentially best-in-class PI3Kα inhibitor. STX-478 is notable for its ability to spare wild-type PI3Kα activity in normal tissues, avoiding the toxicities seen with previous PI3Kα inhibitors, such as hyperglycemia and rash. Tumor reductions were seen in 72% of patients treated with STX-478 as a monotherapy, with circulating tumor DNA levels dropping in 86% of patients. This mutant-selective precision could help overcome the limitations of existing PI3Kα inhibitors, which have struggled with dose-limiting toxicities. In July 2024, Scorpion raised $150 million in a Series C financing round, co-led by Frazier Life Sciences and Lightspeed Venture Partners. The additional funding will support the advancement of STX-478 and other pipeline assets, positioning Scorpion for further clinical success. Scorpion’s pipeline includes a broad range of wholly-owned compounds that target both validated and novel cancer targets, positioning the company for future expansion into larger patient populations. As STX-478 progresses through clinical development, Scorpion is poised to become a significant player in the precision oncology space, making it another company worth watching closely. Optimistic Outlook for Precision Oncology The precision oncology space is experiencing a golden era of innovation, with companies like Summit Therapeutics, Nuvectis Pharma, Silexion Therapeutics, and Scorpion Therapeutics leading the charge. As the focus shifts towards targeted therapies that address resistance mechanisms, the market is increasingly favoring companies with novel approaches and broad applications. Summit’s meteoric rise has shown that there is tremendous potential for companies that can demonstrate efficacy in overcoming cancer resistance. While Summit has already captured much of the current attention, companies like Nuvectis, Silexion, and Scorpion, with their earlier-stage pipelines, offer exciting opportunities for the industry to keep a close eye on. As these companies continue to report clinical data and advance through trials, the potential for breakthroughs in treating some of the most difficult cancers grows stronger. With targeted therapies offering the possibility of overcoming resistance without the need for chemotherapy, the future of cancer treatment looks brighter than ever. For those in the oncology space, keeping a close eye on emerging players like Nuvectis, Silexion, and Scorpion could lead to transformative developments as the field of precision oncology continues to evolve. * * * This update may include speculative forward looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. the BioTech and Pharma industries are volatile and risky and readers are advised to seek out preffesional advice in the relevent feilds from licensed profesionals. This update is for informational purposes only and is not intended to serve as financial, investment or any form of professional advice, recommendation or endorsement. Please review the full documentation detailing financial compensation disclosures and disclaimers the article is subject to. [ https://justpaste.it/ch2qt/pdf ]. Global Markets News Network is a commercial digital brand compensated to provide coverage of news and developments related to innovative companies as detailed in the full documentation and it is thus subject to conflicts of interest. Contact Details News Coverage ronald@futuremarketsresearch.com

September 19, 2024 07:45 AM Eastern Daylight Time

12345 ... 129